Podcasts about stat news

Episode 191: Diagnosis of ADHDFuture Dr. Granat explains how to diagnose Attention Deficit Hyperactivity Disorder. She explained the influence of social media in increasing awareness of ADHD. Dr. Arreaza added input about the validated tools for ADHD diagnosis and highlighted the importance of expert evaluation for the diagnosis of this disorder.  Written by Yen Stephanie Granat, MSIV. Ross University School of Medicine. Comments and editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Steph: I love podcasts—many of us do—and if you, like me, spend any amount of your leisure time listening to podcasts, perusing the news, or scrolling social media; you've likely noticed an alarming trend in the number of discussions we seem to be having about ADHD. It has grown into a very hot topic over the past couple of years, and for some of us, it seems to have even begun sneaking into our “recommended videos” and across our news feeds! Naturally, for the average person this can spur questions like:“Do I have ADHD? Do we all have it? How can I be certain either way, and what do I do if I find myself relating to most of the symptoms that I'm seeing discussed?”Granted that there is a whirlpool of information circulating around this hot topic, I was hoping to spend a bit of time clearly outlining the disorder for anyone finding themselves curious. I believe that can best be achieved through outlining a clear, concise, and easy-to-understand definition of what ADHD is; outlining what it is not; and helping people sift through the fact and the fiction. As with many important things we see discussed on the internet, we're seeing is that there is much more fiction than fact. Arreaza: I'm so glad you chose this topic! I think it is challenging to find reliable information about complex topics like ADHD. Tik Tok, Instagram and Facebook are great social media platforms, but we have to admit that fake news have spread like a fire in recent years. So, if you, listener, are looking for reliable information about ADHD, you are in the right place. With ADHD, there aren't any obvious indicators, or rapid tests someone can take at home to give themselves a reliable “yes” or “no” test result. People's concerns with ADHD are valid, and important to address, so we will discuss the steps to identify some of signs and symptoms they are seeing on TikTok or their favorite podcaster. Steph: Healthcare anxiety is a vital factor to consider when it comes to large cultural conversations around our minds and bodies; so, I hope to sweep away some of the misconceptions and misinformation floating around about ADHD. In doing so, I want to help alleviate any stress or confusion for anyone finding themselves wondering if ADHD is impacting their lives! We might even be able to more accurately navigate these kinds of “viral topics” (for lack of a better term) next time we see them popping up on our news feeds.Arreaza: The first thing I want to say about ADHD is “the crumpled paper sign.”Steph: What is that?Arreaza: It is an undescribed sign of ADHD, I have noticed it, and it is anecdotal, not evidence based. When I walk into a room to see a pediatric patient, I have noticed that when the paper that covers the examination table is crumpled, most of the times it is because the pediatric patient is very active. Then I proceed to ask questions about ADHD and I have been right many times about the diagnosis. So, just an anecdote, remember the crumpled paper sign.  Steph: When you have patients coming to you asking for stimulants because they think they have ADHD, hopefully, after today, you can be better prepared to help those patients. So, for the average person—anyone wanting to be sure if this diagnosis applies to them—how can we really know?”Arreaza: So, let's talk about diagnosis.Steph: Yes, the clearest information we have is the DSM-5, which defines these disorders, as well as outlines the specific criteria (or “checkpoints”) one needs to meet to be able to have a formal diagnosis. However, this manual is best utilized by a trained professional—in this case, a physician—who can properly assess your signs and symptoms and give you a clear answer. Steph: ADHD stands for Attention Deficit Hyperactivity Disorder. It is among the most common neurodevelopmental disorders of childhood. That is not to say it does not affect adult—it does—and because it can be easy to miss, it's very possible for someone to have ADHD without knowing. Arreaza: I recently learned that ADD is an outdated term. Some people with ADHD do not have hyperactivity but the term still applies to them. Steph: Yes, there are multiple types that I will explain in just a bit. But overall the disorder is most simply characterized by a significant degree of difficulty in paying attention, controlling impulsive behaviors, or in being overly active in a way that the individual finds very difficult to control. (CDC)Arreaza: How common is ADHD?Steph: The most recently published data from The CDC estimates that 7 million (11.4%) of U.S. children between the ages of 3 and 17 have been diagnosed with ADHD. For adults, it is estimated that there are 15.5 million (6%) individuals in the U.S. who currently have ADHD. Arreaza: I suspected it would be more than that. [Anecdote about Boy Scout camp]. Steph: I totally agree. With short videos on TikTok, or paying high subscription fees to skip ads, it feels like as a society we all have a shorter attention span. Arreaza: Even churches are adapting to the new generation of believers: Shorter sermons and shorter lessons.Steph: When it comes to better understanding these numbers, it's also important to know that there are three distinct presentations of ADHD recognized by The CDC and The World Health Organization. Arreaza: The DSM-5 TR no longer uses the word “subtypes” for ADHD. Instead, it uses the word "presentation" to describe the different ways that ADHD may manifest in a person. That reminded me to update my old DSM-5 manual and I ordered it while reading today about ADHD. This means people with ADHD are no longer diagnosed as having a “subtype”. Instead, they are diagnosed with ADHD and a certain “presentation” of symptoms.Steph: These presentations are:Inattentive TypePeople often have difficulty planning or completing tasksThey find themselves easily distracted (especially when it comes to longer, focus-oriented tasks)They can often forget details and specifics, even with things that are part of their daily routineThis used to be referred to as “ADD” (you'll notice the absence of an “H”, segue).Hyperactive-Impulsive TypePeople often have a sense of intense “restlessness”, noticeable even in calm environments.They tend to be noticeably more talkative, and might often be seen interrupting others, or finishing their sentences.They find significant difficulty in being still for extended periods. Because of this, they are often unable to sit through a movie or class time, without fidgeting or getting up and moving around.With this category of ADHD, we often see an impulsiveness that unwittingly leads to risky behavior. Because of this, accidents and bodily injury are more common in individuals with this type of ADHD.Combined TypeThese are individuals who exhibit symptoms from both “Inattentive” and “Hyperactive-Impulsive” ADHD equally.Some listeners might have noticed that the categories are quite different, meaning that ADHD presents in different ways depending on the person! Two people who have ADHD can be in the same room and have vastly different presentations, whilst still having many of the same types of challenges. You also might have noticed what makes the discussion so interesting to the general public, which is also the thing that makes speaking to a professional to get formally tested so important:The diagnostic criteria rely heavily on patterns of behavior, or external variables; rather than on how a person might feel, or certain measurements taken from lab tests.Arreaza: Diagnosing ADHD requires evaluation by a professional who is properly trained for this. Fortunately, we have tools to assist with the diagnosis. The attention deficit must be noted in more than one major setting (e.g., social, academic, or occupational), that's why the information should be gathered from multiple sources, including parents, teachers, and other caregivers, using validated tools, such as:The Neuropsychiatric EEG-Based ADHD Assessment Aid (NEBA), recommended by the American Academy of NeurologyThe Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) and the Vanderbilt ADHD Diagnostic Teacher Rating Scale (VADTRS), recommended by the Society for Developmental and Behavioral Pediatrics.For adults: The validated rating scales include the Adult ADHD Self-Report Scale (ASRS) and the Conners Adult ADHD Rating Scales (CAARS).Steph: This is important because nearly everyone alive has experienced several, if not most, of these behavioral patterns at least once. Whether or not an individual has ADHD, I'm certain we could all think of moments we've had great difficulty focusing or sitting still. Perhaps some of us are incredibly forgetful, or act more impulsively than the average person might find typical. Getting a professional diagnosis is important because it is in skillfully assessing “the bigger picture” of a person's life, or their patterns of behavior, that a skilled physician, who understands the nuances and complexities in these disorders, can properly tell each of us whether we have ADHD, or not.Essentially, most of us could stand to use a bit more focus these days, but far fewer of us would meaningfully benefit from the kinds of treatments and therapies needed by individuals with ADHD to live healthier, more happy and regulated lives.Arreaza: I had a mother who came to discuss the results of the Vanderbilt Questionnaire. I think she left a little disappointed when she heard that, based on the responses from her and the teacher, her son did not have ADHD. Some kids may have behaviors such as being distracted during a meeting, forgetting about homework or having a lot of energy, but that does NOT mean necessarily that they have ADHD, right?Steph: Absolutely! The important thing to remember here is that these patterns of behavior outlined in the DSM-5 are merely an external gauge for a neurological reality. What the science is showing us is that the brains of people with ADHD are wired differently than that of the more “neurotypical” brain. Much like a check engine light would serve as a signal to a driver that something under the hood needs attention; these patterns of behavior, when they begin impeding our day to day lives, might tell us that it's time to see a professional (whether it be an auto mechanic or a trained physician). I think we all know someone who drives with their check engine light and not a care in the world. Arreaza: How serious/urgent is ADHD? Why should we care to make the diagnosis?Steph: Although we've yet to see anyone incur harm solely from having ADHD, it does lead to quite a range of more serious issues, some of which might prove more urgent. In the cases of ADHD, specifically, what we know is that there is a notable degree of dysregulation in some key neurotransmitters, like dopamine and norepinephrine. More plainly, what we are seeing in the brains of people with ADHD is a disruption, or alteration, of some of the brain's key chemicals.These neurotransmitters are largely responsible for much-needed processes like Motivation, Satisfaction, Focus, Impulse control, even things like energy and feelings of happiness. Many of these things serve as “fuel” for our day-to-day lives; things we'd call our “executive function”.  These are also what prove dysfunctional in those struggling with ADHD. It is in this sense that we might be able to bridge a meaningful gap between ADHD as being seen through patterns of behaviorthat signal a real, neurological reality.Steph: We often hear of the brain referenced as a kind of supercomputer. A more accurate assessment might be that the brain is more of a network of interconnected computers that run different processes and require continual communication with one another for our brain to function properly and seamlessly. What we're seeing in members of the population with this diagnosis, is a significant disruption in these lines of communication. Although this is a very broad oversimplification, for the purposes of our metaphor is to think of it like our brain chemicals getting caught in a traffic jam, or parts of our brain attempting to communicate to one another with poor cell signal. Arreaza: Making the diagnosis is critical to start treatment because having that level of dysfunction sounds like having a very difficult life.Steph: Yeah! I think that's why this conversation matters so much. There's a sense of urgency there, because much of life is, in fact, boring. Things like paying bills, exercising and eating well, work and school—these are all things that are vital to health and wellbeing in day-to-day life; and for the more neurotypical brain, these things might prove occasionally challenging. Yet, they are still doable. For those with ADHD however, this goes far beyond mere boredom or “laziness” (which proves to be a trigger term for many—more on that in just a bit).For folks listening, I wanted to offer some statistics that show why this is such a big concern for the public, whether one has a formal ADHD diagnosis or not. The facts are figures are:Children with ADHD are more than five times as likely as the child without ADHD to have major depression.A significant increase in the prevalence of anxiety is seen in ADHD patients, ranging from 15% to 35%, when accounting for overlap in symptoms.There are significant correlations in youth diagnosed with ADHD, and those diagnosed with what are known as “externalizing disorders”. These are things like Conduct Disorder, Disruptive Mood Dysregulation Disorder, and Oppositional Defiant Disorder.We are seeing a much higher rate of academic problems in kids who have ADHD, like reading disorder, impaired verbal skills, and visual motor integration.We're finding that many, if not most, of these connections are being made after diagnosis. In the case of the “internalized disorders”, like depression and anxiety, we're often seeing years between ADHD diagnoses and the diagnoses of major depressive disorder or anxiety disorders. Given this framework, much of the data is theorized to point towards what we call “negative environmental circumstances”, otherwise known as “ADHD-related demoralization”.For children, this often looks like struggling with sitting still during class, failing to get homework done (because they forgot, or couldn't focus on the tasks at hand), and struggling to focus their attention on what their teacher is saying during lecture. These things often lead to bad grades, discipline or forced time sitting still in detention. This can be seen in more problems at home, with children being disciplined often for behavior that they struggle immensely to control.For adults, this can mean forgetting to pay your bills, missing work meetings, having trouble making appointments, or having difficulty with day-to-day tasks, really anything that requires sustained attention. We often see adults with ADHD who are chasing normalcy with caffeine addictions or even struggling with substance use. Arreaza: Substance use disorder actually can be a way for some people living with ADHD to self-treat their symptoms. Steph: These differences between the individual's experience and the world around them can lead to really powerful feelings of failure or inadequacy. They can affect your social life, your sense of community, and even further limit your capacity to seek help.Literacy in these things is so important—not just for the individual who feels that they may have ADHD, but also for those who are likely to encounter people with ADHD in their own lives. Understanding why some of these patterns pop up, even those who might not have a formal diagnosis, can go a long way to properly approaching these behaviors with success and with empathy.Arreaza: Learning about ADHD is fundamental for primary care doctors. We talked about the high prevalence and the influence of the media in increasing awareness and sometimes increasing public panic. So, we have to be prepared to diagnose or undiagnosed ADHD. Steph: Whether we're the physicians in the room, or the patient in the chair, I think it's important to have a clear understanding of what ADHD is and how it can affect lives. Thanks for listening, I hope we were able to teach you a little more about ADHD. ______________Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _______________References:NICHQ-Vanderbilt-Assessment-Scales PDF: https://nichq.org/wp-content/uploads/2024/09/NICHQ-Vanderbilt-Assessment-Scales.pdfADHD: The facts. ADDA - Attention Deficit Disorder Association. (2023, January 11). https://add.org/adhd-facts/American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596.Gnanavel S, Sharma P, Kaushal P, Hussain S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420. PMID: 31559278; PMCID: PMC6745333.Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October – November 2023. CDC.Gov, MMWR Morb Mortal Wkly Rep 2024;73:890-895.Danielson ML, Claussen AH, Arifkhanova A, Gonzalez MG, Surman C. Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021. J Atten Disord. 2024 Jun;28(8):1225-1235. doi: 10.1177/10870547241238899. Epub 2024 Mar 18. PMID: 38500256; PMCID: PMC11108736. https://pubmed.ncbi.nlm.nih.gov/38500256/Mattingly G, Childress A. Clinical implications of attention-deficit/hyperactivity disorder in adults: what new data on diagnostic trends, treatment barriers, and telehealth utilization tell us. J Clin Psychiatry. 2024;85(4):24com15592. https://www.psychiatrist.com/jcp/implications-adult-adhd-diagnostic-trends-treatment-barriers-telehealth/Didier J. My four kids and I all have ADHD. We need telehealth options. STAT News. Published October 10, 2024. Accessed October 10, 2024. https://www.statnews.com/2024/10/10/adhd-medication-shortage-telehealth-dea-congress/.Hong J, Mattingly GW, Carbray JA, Cooper TV, Findling RL, Gignac M, Glaser PE, Lopez FA, Maletic V, McIntyre RS, Robb AS, Singh MK, Stein MA, Stahl SM. Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder. CNS Spectr. 2024 May 20:1-12. doi: 10.1017/S1092852924000208. Epub ahead of print. PMID: 38764385. https://pubmed.ncbi.nlm.nih.gov/38764385/Gabor Maté: The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture. (2022). Youtube. Retrieved April 27, 2025, from https://www.youtube.com/watch?v=ttu21ViNiC0. Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Sponsored by: Set for LifeSet For Life Insurance helps doctors safeguard their future with True Own Occupational Disability Insurance. A single injury or illness can change everything, but the best physicians plan ahead. Protect your income and secure your future before life makes the choice for you. Your career deserves protection—act now at https://www.doctorpodcastnetwork.co/setforlife_______________ In an era where misinformation can masquerade as science, how do you discern credible research? Host Dr. Bradley Block welcomes Dr. Katie Suleta, to unpack the importance of scrutinizing study authors and journals for conflicts of interest. Drawing from her recent experience with the Journal of Personalized Medicine, where a case study on supplements for autism treatment failed to disclose a lead author's affiliation with a supplement company, Dr. Suleta shares her journey to push for its retraction. This episode equips physicians with tools to inoculate themselves against junk science, emphasizing intellectual humility and lateral reading to protect patient care and public trust.Three Actionable Takeaways:Check Author Affiliations – Before reading a study, investigate authors' affiliations and potential conflicts of interest using readily available information to assess bias.Evaluate Journal Credibility – Be wary of journals with overly long or suspicious titles, and research their reputation to avoid predatory publications.Practice Lateral Reading – Cross-check studies or news articles with other sources to verify credibility and understand broader reactions, enhancing your information hygiene.About the Show:PGD  Physician's Guide to Doctoring covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Katie Suleta is a trained epidemiologist with expertise in infectious diseases and health informatics, serving as the regional director of research and graduate medical education. She mentors residents daily and works as a science writer, contributing to outlets like the American Council on Science and Health, The Conversation, Skeptical Inquirer, and STAT News. Known for her advocacy against misinformation, Dr. Saleta recently exposed a case study in the Journal of Personalized Medicine where a lead author's undisclosed supplement company affiliation led her to push for its retraction, highlighting the need for transparency in scientific publishing.LinkedIn: http://linkedin.com/in/katherine-sota-ortecho-447a4899Instagram: https://www.instagram.com/katysota?igsh=Njd0NG4weW90OWJiAbout the Host Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts The Physician's Guide to Doctoring podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

A recent survey surprisingly found only 41% of physicians were “very confident” about their ability to provide equal quality care to patients with a disability. Megan Morris, Ph.D., and her allies are trying to figure out why and how to boost that percentage. STAT News' STATUS List recently added Morris to its prestigious collection of influencers because of her role as founder of the Disability Equity Collaborative. In an interview with “Conversations on Health Care” hosts Mark Masselli and Margaret... Read More Read More The post Healthcare Disability Advocate, Fueled by Personal Experience: Megan Morris appeared first on Healthy Communities Online.

Erik och Jacob diskuterar två debattartiklar denna vecka. Först ut är en artikel i Aftonbladet av Fanny Nilsson med titeln ”Är det lösningen – ska alla ta Ozempic nu?” där hon tar upp det positiva med att det finns fetmamediciner samtidigt som hon kritiserar politiker och samhället för att det inte sker några förändringar av miljön som påverkar så många människor negativt när det gäller hälsa. Efter det diskuteras en artikel i STAT News skriven av lågkolhydratkostförespråkaren David Ludwig där han kritiserar kortsiktiga dietstudier i en debattartikel med titeln ”Short-term diet trials are designed to fail”. Ludwig tycker inte att de väldigt välkontrollerade studierna på några enstaka veckor ger tillräckligt bra information utan istället säger han att man måste samla in pengar nog för att genomföra stora långvariga dietstudier där man testar olika dieter mot varandra. Framför allt eftersöker han studier på lågkolhydratkost över längre tid. På Hälsoveckan by Tyngres instagram kan du hitta bilder relaterat till detta och tidigare avsnitt. Hålltider (00:00:00) Introsnack (00:03:32) Fanny Nilsson om Ozempic och samhällets apati mot att försöka förbättra folkhälsan (00:24:33) David Ludwig tycker inte att korta välkontrollerade studier är bra

Jason Resendez joins host Ron Aaron and co-host Carol Zernial to talk about the policy environment for caregiver supports on this edition of Caregiver SOS. About Jason Jason Resendez is a nationally recognized care advocate. He currently serves as the President and CEO of the National Alliance for Caregiving, where he leads research, policy, and programmatic initiatives to build health, wealth, and equity for America’s 53 million family caregivers. In 2023, Jason was named one of the most consequential leaders in health and medicine by STAT News. Prior to joining NAC, Jason was the founding executive director of the UsAgainstAlzheimer’s Center for Brain Health Equity where he pioneered the concept of Brain Health Equity through peer-reviewed research, public health partnerships, and public policy. In 2020, Jason was named one of America’s top influencers in aging by PBS’s Next Avenue alongside Michael J. Fox and Surgeon General Dr. Vivek Murthy. He has been quoted by The New York Times, The Washington Post, The Wall Street Journal, STAT News, and Univision on issues related to caregiving and health equity. Jason is from South Texas and graduated from Georgetown University. Hosts Ron Aaron and Carol Zernial, and their guests talk about Caregiving and how to best cope with the stresses associated with it. Learn about "Caregiver SOS" and the "Teleconnection Hotline" programs.See omnystudio.com/listener for privacy information.

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers welcomes Bob Herman of STAT News to the program to discuss the state of deals in the health care space, how vertical integration and consolidation have played a role in mergers & acquisitions as it relates to hospitals, and what might fly under the radar from even the most savvy of health policy wonks.Health Affairs Insiders can join us April 23 for an exclusive virtual event exploring site-neutral payments with health economist and health services researcher Brady Post of Northeastern University and Health Affairs' Meg Winchester.Also, we are hosting another Insider exclusive event on May 29 focusing on the FDA's first 100 days under the second Trump administration featuring moderator Rachel Sachs alongside panelists Richard Hughes IV and Arti Rai. Related Links:Sign up for STAT+Sign up for STAT newsletters including Bob Herman's Health Care Inc. Subscribe to UnitedHealthcare's Community & State newsletter.

El Salvador President Nayib Bukele said he will not help return Kilmar Abrego Garcia to the U.S. after Garcia was mistakenly deported to El Salvador. NBC News has more. And Rolling Stone reports on private White House considerations about sending U.S. citizens there as well. Joseph Walker from the Wall Street Journal joins to talk about a possible way that Republicans could cut Medicaid funding. Anil Oza, Sharon Begley fellow at Stat News, discusses the rise in U.S. maternal mortality rates. Plus, Harvey Weinstein goes back on trial, an internal government memo refutes the narrative behind the detainment of a Tufts University student, UConn star Paige Bueckers was selected first in the WNBA draft, and why the IRS is extending the tax-filing deadline for certain states. Today’s episode was hosted by Shumita Basu.

Here are today's top stories from The Morning Pulse: 1. U.S. financial regulator says email hack exposed sensitive data on banks - CNBC https://www.cnbc.com/2025/04/08/occ-email-hack-sensitive-bank-data.html 2. ABA survey: Americans oppose policies that threaten credit card rewards programs https://bankingjournal.aba.com/2025/04/aba-survey-americans-oppose-policies-that-threaten-credit-card-rewards-programs/ 3. AI agents slowly gaining a foothold in health care industry - STAT News https://www.statnews.com/2025/04/09/ai-agents-gain-foothold-health-care-industry-but-issues-remain-safety-reliability/ 4. India, China, and the US will drive global diabetes burden by 2050, study finds https://www.news-medical.net/news/20250409/India-China-and-the-US-will-drive-global-diabetes-burden-by-2050-study-finds.aspx Subscribe for all these stories and more delivered to your inbox daily by visiting www.broadcastretirementnetwork.com

On this episode we're joined by Lizzy Lawrence. Lizzy covers the Food and Drug Administration for STAT News, a subscription-based part of Boston Globe's media newsroom owned by the Boston Globe that covers the frontiers of health and medicine. As they say- "We take you inside the science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health." Lizzy has been with them for 2 1/2 years and she's been part of stories that have won prominent awards. She's previously covered technology and was editor-in-chief of the University of Michigan's student newspaper. And she's a graduate of my alma mater, Stuyvesant High School in New York City.Lizzy talked about what it's like to cover both breaking news, like the mass firing of thousands of people at the FDA and bigger enterprise stories, like the team coverage on United Healthcare that won a Polk Award for investigative journalism. She shared the biggest lessons she learned and what she feels she's taken from being a journalist.Lizzy's salute: The Association of Health Care JournalistsA detailed interview explaining STAT's coverage of United Healthcarehttps://www.youtube.com/watch?v=B0VJGEv5IGwThank you as always for listening. Please send us feedback to journalismsalute@gmail.com Visit our website: thejournalismsalute.org Mark's website (MarkSimonmedia.com)Tweet us at @journalismpod and Bluesky at @marksimon.bsky.socialSubscribe to our newsletter– journalismsalute.substack.com

The Trump Administration began terminating thousands of staff and purging some of the top leaders at the Department of Health and Human Services. It included several key agencies, including the Food and Drug Administration, the National Institutes of Health and the Centers for Disease Control and Prevention. Geoff Bennett discussed more with Matthew Herper of STAT News. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Send us a textIn this packed episode of Neo News, Eli, Ben, and Daphna dive into the headlines impacting neonatology and public health. The trio starts with the controversial confirmation of Robert F. Kennedy Jr. as head of HHS, analyzing his actions around the CDC, NIH, vaccine policy, and the implications of promoting “informed consent” messaging in place of public health advocacy. Drawing from reporting by The New York Times, STAT News, and Science Magazine, the team unpacks how these shifts could affect vaccine uptake in the NICU.Next, they examine the threat to birthright citizenship in the U.S., based on analysis from The New York Times, and how immigration policy may directly impact NICU families' access to care and trust in healthcare systems.They also discuss a Wall Street Journal article detailing the erosion of trust in physicians post-pandemic and the fallout from a recent JAMA Pediatrics study on therapeutic hypothermia in late preterms, which raised questions about research transparency.Other highlights include studies from Scientific Reports, JAMA Network Open, and The New York Times on air pollution, paternity leave, language-concordant care, and breastfeeding. The show ends with a call to action from Dr. Shadel Shah's op-ed advocating for the continuation of the PREEMIE Act. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Drug policy in America is at a critical inflection point. Following a period dominated by extreme harm reduction approaches, we're witnessing a significant shift back toward accountability-based treatment models. This transformation comes as cities like San Francisco and states like Oregon roll back failed experiments that provided tools for addiction without addressing its root causes.Dr. Kevin Sabet joins us fresh from United Nations meetings in Vienna, where American representation was noticeably diminished – a symptom of the current administration's still-developing drug policy strategy. Together, we analyze Dr. Nora Volkow's recent Stat News interview, where the longtime NIDA Director expressed skepticism about universalizing 12-step approaches despite compelling research supporting their effectiveness. As Sabet points out, studies from leading institutions demonstrate that 12-step programs often outperform traditional psychotherapy while lowering healthcare costs.The encouraging decline in opioid overdose deaths presents a complex puzzle we attempt to unravel. Is it increased naloxone availability? Greater public awareness of fentanyl dangers? The tragic reality that many vulnerable users have already died? The answer likely combines these factors, highlighting why comprehensive approaches that blend harm reduction tools with accountability-focused recovery pathways remain essential. As America recalibrates its drug policy strategy, this conversation offers crucial context for understanding what works, what doesn't, and why the pendulum is swinging back toward treatment models that emphasize personal responsibility alongside compassionate care.Follow the work of SAM and FDPS below:https://learnaboutsam.org/https://gooddrugpolicy.org/https://thedrugreport.org/On X: https://twitter.com/learnaboutsamhttps://twitter.com/GoodDrugPolicyhttps://twitter.com/KevinSabethttps://twitter.com/LukeNiforatosOn Facebook: https://www.facebook.com/learnaboutsam

On today’s show: It’s been a busy week for Tesla and Elon Musk. The Wall Street Journal’s Becky Peterson explains how his relationship with Trump is impacting his businesses. Sarah Owermohle from Stat News dives deep into the past of CDC nominee Dave Weldon and his prior anti-vaccine stances. The Washington Post’s Mary Beth Sheridan examines Trump's unique relationship with Mexican President Claudia Sheinbaum. Plus, a judge says Palestinian activist Mahmoud Khalil will remain in a Louisiana immigration jail for now, why a congressional hearing came to an abrupt end over gender identity, and the surprising outcome of Greenland’s election. Today’s episode was hosted by Shumita Basu.

Listen to ASCO's Journal of Clinical Oncology Art of Oncology article, "I Hope So Too” by Dr. Richard Leiter from Dana-Farber Cancer Institute. The article is followed by an interview with Leiter and host Dr. Mikkael Sekeres. Leiter shares that even in the most difficult moments, clinicians can find space to hope with patients and their families. TRANSCRIPT  Narrator: I Hope So Too, by Richard E. Leiter, MD, MA  “You're always the negative one,” Carlos' mother said through our hospital's Spanish interpreter. “You want him to die.” Carlos was 21 years old. A few years earlier he had been diagnosed with AML and had undergone an allogeneic bone marrow transplant. He was cured. But now, he lay in our hospital's bone marrow transplant (BMT) unit, his body attacked by the very treatment that had given him a new life. He had disseminated graft-versus-host disease (GVHD) in his liver, his lungs, his gut, and, most markedly, his skin. The BMT team had consulted us to help with Carlos' pain. GVHD skin lesions covered his body. They were raw and weeping. Although the consult was ostensibly for pain, the subtext could not have been clearer. Carlos was dying, and the primary team needed help navigating the situation. As his liver and kidney function declined, the need to address goals of care with Carlos' mother felt like it was growing more urgent by the hour. Difficult cases, like a young person dying, transform an inpatient unit. Rather than the usual hum of nurses, patient care associates, pharmacy technicians, and unit managers going about their daily work, the floor becomes enveloped in tension. Daily rhythms jump a half step ahead of the beat; conversations among close colleagues fall out of tune. “Thank goodness you're here,” nurse after nurse told my attending and me, the weight of Carlos' case hanging from their shoulders and tugging at the already puffy skin below their eyes. I was a newly minted palliative care fellow, just over a month into my training. I was developing quickly, but as can happen with too many of us, my confidence sat a few steps beyond my skills. I thought I had a firm grasp of palliative care communication skills and was eager to use them. I asked for feedback from my attendings and genuinely worked to incorporate it into my practice. At the same time, I silently bristled when they took charge of a conversation in a patient's room. Over the ensuing week, my attending and I leaned in. We spent hours at Carlos' bedside. If I squinted, I could have convinced myself that Carlos' pain was better. Every day, however, felt worse. We were not making any progress with Carlos' mother, who mostly sat silently in a corner of his room. Aside from occasionally moaning, Carlos did not speak. We learned little, if anything, about him as a person, what he enjoyed, what he feared. We treated him, and we barely knew him. Each morning, I would dutifully update my attending about the overnight events. “Creatinine is up. Bili is up.” She would shake her head in sadness. “Doesn't she get that he's dying?” one of the nurses asked us. “I feel like I'm torturing him. He's jaundiced and going into renal failure. I'm worried we're going to need to send him to the ICU. But even that won't help him. Doesn't she understand?”  We convened a family meeting. It was a gorgeous August afternoon, but the old BMT unit had no windows. We sat in a cramped, dark gray family meeting room. Huddled beside Carlos' mother was everyone on the care team including the BMT attending, nurse, social worker, chaplain, and Spanish interpreter. We explained that his kidneys and liver were failing and that we worried time was short. Carlos' mother had heard it all before, from his clinicians on rounds every day, from the nursing staff tenderly caring for him at his bedside, and from us. “He's going to get better,” she told us. “I don't understand why this is happening to him. He's going to recover. He was cured of his leukemia. I have hope that his kidneys and liver are going to get better.” “I hope they get better,” I told her. I should have stopped there. Instead, in my eagerness to show my attending, and myself, I could navigate the conversation on my own, I mistakenly kept going. “But none of us think they will.” It was after this comment that she looked me right in the eyes and told me I wanted Carlos to die. I knew, even then, that she was right. In that moment, I did want Carlos to die. I could not sit with all the suffering—his, his mother's, and his care team's. I needed her to adopt our narrative—that we had done all we could to help Carlos live, and now, we would do all we could to help him die comfortably. I needed his mother to tell me she understood, to accept what was going on. I failed to recognize what now seems so clear. Of course, his mother understood what was happening. She saw it. But how could we have asked her to accept what is fundamentally unacceptable? To comprehend the incomprehensible?  At its best, serious illness communication not only empathetically shares news, be it good or bad, but also allows patients and families adequate time to adjust to it. For some, this adjustment happens quickly, and in a single conversation, they can digest difficult news and move to planning the next steps in care for themselves or their loved ones. For most, they need more time to process, and we are able to advance the discussion over the course of multiple visits. My attending led the conversations from then on. She worked with the BMT attending, and they compassionately kept Carlos out of the intensive care unit. He died a few days later, late in the evening. I never saw his mother again. I could not have prevented Carlos' death. None of us could have. None of us could have spared his mother from the grief that will stay with her for the rest of her life. Over those days, though, I could have made things just a little bit less difficult for her. I could have protected her from the overcommunication that plagues our inpatient units when patients and families make decisions different from those we would make for ourselves and our loved ones. I could have acted as her guide rather than as her cross-examiner. I could have hoped that Carlos stopped suffering and, genuinely, hoped he got better although I knew it was next to impossible. Because hope is a generous collaborator, it can coexist with rising creatinines, failing livers, and fears about intubation. Even in our most difficult moments as clinicians, we can find space to hope with our patients, if we look for it. Now—years later, when I talk to a terrified, grieving family member, I recall Carlos' mother's eyes piercing mine. When they tell me they hope their loved one gets better, I know how to respond. “I hope so too.” And I do. Dr. Mikkael Sekeres: Hello and welcome to JCO's Cancer Stories: The Art of Oncology, which features essays and personal reflections from authors exploring their experience in the oncology field. I'm your host, Mikkael Sekeres. I'm professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center at University of Miami. Today I am thrilled to be joined by Dr. Ricky Leiter from the Dana-Farber Cancer Institute. In this episode, we will be discussing his Art of Oncology article, “I Hope So, Too.” Our guest's disclosures will be linked in the transcript. Ricky, welcome to our podcast and thank you so much for joining us. Dr. Ricky Leiter: Thanks so much for having me. I'm really excited to be here. Dr. Mikkael Sekeres: Ricky, I absolutely adored your essay. It really explored, I think, a combination of the vulnerability we have when we're trying to take care of a patient who's dying and the interesting badlands we're placed in when we're also a trainee and aren't quite sure of our own skills and how to approach difficult situations. But before we dive into the meat of this, can you tell us a little bit about yourself? Where are you from and where did you do your training? Dr. Ricky Leiter: Sure, yeah. Thanks so much. So I grew up in Toronto, Canada, and then moved down to the States for college. I was actually a history major, so I never thought I was going to go into medicine. And long story short, here I am. I did a Post-Bac, did a year of research, and ended up at Northwestern Feinberg School of Medicine for med school, where I did a joint degree in medical humanities and bioethics. And that really shaped my path towards palliative care because I found this field where I said, “You know, wow, I can use these skills I'm learning in my Master's at the bedside with patients thinking about life and death and serious illness and what does that all mean in the broader context of society.” So, moved from Chicago to New York for residency, where I did residency and chief residency in internal medicine at New York Presbyterian Cornell, and then came up to the Harvard Interprofessional Palliative Care Program, where I did a clinical fellowship, then a research fellowship with Dana-Farber, and have been on faculty here since. Dr. Mikkael Sekeres: Fantastic. Any thoughts about moving back to Canada? Dr. Ricky Leiter: We talk about it every now and then. I'm really happy here. My family's really happy here. We love life in Boston, so we're certainly here for the time being. Definitely. Dr. Mikkael Sekeres: And the weather's so similar. Dr. Ricky Leiter: Yeah, I'm used to the cold. Dr. Mikkael Sekeres: I apparently did not move to Miami. I'm curious, this may be an unfair question, as you have a really broad background in humanities and ethics. Are there one or two books that you read where you think, “Gee, I'm still applying these principles,” or, “This really still resonates with me in my day to day care of patients who have cancer diagnosis”? Dr. Ricky Leiter: Oh, wow, that is a great question. There are probably too many to list. I think one is When Breath Becomes Air by Paul Kalanithi, which I didn't read in my training, I read afterwards. And I think he's such a beautiful writer. The story is so poignant, and I just think Paul Kalanithi's insights into what it means to be living with a serious illness and then ultimately dying from cancer as a young man, as someone in medicine, has really left an imprint on me. Also, Arthur Kleinman. The Illness Narratives, I think, is such a big one, too. And similarly, Arthur Frank's work. I mean, just thinking about narrative and patient stories and how that impacts our clinical care, and also us as clinicians. Dr. Mikkael Sekeres: And I suspect us as writers also. Dr. Ricky Leiter: Absolutely. Dr. Mikkael Sekeres: We imprint on the books that were influential to us. Dr. Ricky Leiter: Certainly. Dr. Mikkael Sekeres: So how about your story as a writer? How long have you been writing narrative pieces? Is this something you came to later in your career, or did you catch the bug early as an undergrad or even younger? Dr. Ricky Leiter: So I caught it early, and then it went dormant for a little while and came back. As a history major, as someone who is humanities minded, I loved writing my papers in college. Like, I was one of those nerds who got, like, really, really excited about the history term paper I was writing. You know, it was difficult, but I was doing it, particularly at the last minute. But I really loved the writing process. Going through my medical training, I didn't have as much time as I wanted, and so writing was sort of on the back burner. And then actually in my research fellowship, we had a writing seminar, our department, and one of the sessions was on writing Op-eds and perspective pieces. And we had a free write session and I wrote something sort of related to my research at the time I was thinking about, and Joanne Wolfe, who was helping to lead the session, pediatric palliative care physician, she said, “You know, this is really great. Like, where are you going to publish this?” And I said, “Joanne, what do you mean? I just wrote this in this session as an exercise.” She said, “No, you should publish this.” And I did. And then the bug came right back and I thought, “Wow, this is something that I really enjoy and I can actually make a difference with it. You know, getting a message out, allowing people to think a little bit differently or more deeply about clinical cases, both in the lay press and in medical publications.: So I've essentially been doing it since and it's become a larger and larger part of my career. Dr. Mikkael Sekeres: That's absolutely wonderful, Ricky. Where is it that you publish then, outside of Art of Oncology? Dr. Ricky Leiter: So I've had a couple of pieces in the New York Times, which was really exciting. Some in STAT News on their opinion section called First Opinion, and had a few pieces in the New England Journal as well, and in the Palliative Care Literature, the Journal of Palliative Medicine. Dr. Mikkael Sekeres: Outstanding. And about palliative care issues and end of life issues, I assume? Dr. Ricky Leiter: Sort of all of the above. Palliative care, serious illness, being in medical training, I wrote a fair bit about what it was like to be on the front lines of the pandemic. Dr. Mikkael Sekeres: Yeah, that was a traumatic period of time, I think, for a lot of us. Dr. Ricky Leiter: Absolutely. Dr. Mikkael Sekeres: I'm curious about your writing process. What triggers a story and how do you face the dreaded blank page? Dr. Ricky Leiter: So it's hard to pin down exactly what triggers a story for me. I think sometimes I'm in a room and for whatever reason, there's a moment in the room and I say, “You know what? There's a story here. There's something about what's going on right now that I want to write.” And oftentimes I don't know what it is until I start writing. Maybe it's a moment or a scene and I start writing like, “What am I trying to say here? What's the message? And sometimes there isn't a deeper message. The story itself is so poignant or beautiful that I want to tell that story. Other times it's using that story. And the way I think about my writing is using small moments to ask bigger questions in medicine. So, like, what does it mean to have a good death? You know, one piece I wrote was I was thinking about that as I struggled to give someone what I hoped would be a good death, that I was thinking more broadly, what does this mean as we're thinking about the concept of a good death? Another piece I wrote was about a patient I cared for doing kidney palliative care. And she was such a character. We adored her so much and she was challenging and she would admit that. This was someone I wanted to write about. And I talked to her about it and she was honored to have her story told. Unfortunately, it came out shortly after her death. But she was such a vibrant personality. I said, “There's something here that I want to write about.” In terms of the blank page, I think it's overcoming that fear of writing and procrastination and all of that. I think I have a specific writing playlist that I put on that helps me, that I've listened to so many times. You know, no words, but I know the music and it really helps me get in the zone. And then I start writing. And I think it's one of those things where sometimes I'm like, “Oh, I really don't like how this is sounding, but I'm going to push through anyways.” as Anne Lamott's blank first draft, just to get something out there and then I can play with it and work with it. Dr. Mikkael Sekeres: Great. I love the association you have with music and getting those creative juices flowing and picking ‘le mot juste' in getting things down on a page. It's also fascinating how we sometimes forget the true privilege that we have as healthcare providers in the people we meet, the cross section of humanity and the personalities who can trigger these wonderful stories. Dr. Ricky Leiter: Absolutely. Absolutely. It's such a privilege and I think it often will go in unexpected directions and can really impact, for me certainly, my practice of medicine and how I approach the next patients or even patients years down the road. You remember those patients and those stories. Dr. Mikkael Sekeres: Right. You write with such obvious love and respect for your patients. You also write about that tenuous phase of our careers when we're not yet attendings but have finished residency and have demonstrated a modicum of competence. You know, I used to say that fellowship is really the worst of all worlds, right? As an attending, you have responsibility, but you don't have to do as much of the grunt work. As a resident, you do the grunt work, but you don't really have the responsibility. And in fellowship, you've got it all. You've got to do the grunt work, and you have the responsibility. Can you tie those two concepts together, though? How does our relationship to our patients change over the course of our careers? Dr. Ricky Leiter: Early on, if you think about the imprinting of patients as you go down the road, so many of the patients who have imprinted on me were the ones earlier in my career, before I was more formed as a clinician because of experiences like the one I wrote about in “I Hope so Too,” where the skills are forming, and sometimes where it's smooth sailing, and sometimes we're muddling through. And those cases where we feel like we're muddling through or things don't go as we hope, those are the ones that really leave an impact. And I think it's those little moments that sort of nudge your career and your skill set in different ways. I think the patients now, they still leave a mark on me, but I think it's in different ways. And I think oftentimes it's less about my skills. Although my skills are still very much developing, even, you know, almost a decade out, they impact me differently than they once did. I feel more confident in what I'm doing, and it's more about my relationship to this situation rather than the situation's impact on my skills. Dr. Mikkael Sekeres: Got it. Got it. It's interesting. I once wrote a piece with Tim Gilligan, who also spent some time at Dana Farber and is a communications expert, about how there's this kind of dualism in how we're trained. We're trained with communications courses and how to talk to patients, and it almost does the opposite. It kind of raises the flag that, “Wait a second, maybe I've been talking to people the wrong way.” And as you get more mature in your career, I almost feel as if you revert back to the way you were before medical school, when you just talked to people like they were people and didn't have a special voice for patients. Dr. Ricky Leiter: Yeah, I think that's right. And I think in palliative care, we spend so much time thinking about the communication. And this was the most challenging piece about fellowship because then- and our fellowship directors told this to us, and now we teach it to our fellows. You know that you come in, the people who choose to go into palliative care, have a love of communication, have some degree of skill coming in, and then what happens is we break those skills down and teach them a new skill set. So it gets clunkier before it gets better. And the time I was writing about in this piece was August of my fellowship year, exactly when that process was happening, where I'm trying to incorporate the new skills, I had my old way of doing things, and it's just not always aligning. And I think you're right that as the skills become embedded, as you go on throughout your career, where it feels much more natural, and then you do really connect with people as people still using the skills and the techniques that we've learned in our communication courses, but they become part of who you are as a clinician. Dr. Mikkael Sekeres: Nicely put. Your story is particularly poignant because the patient you described was dying from the very treatment that cured his leukemia. It's this, I'm going to use the term badlands again. It's this terrible badlands we sometimes find ourselves where, yes, the treatment has been successful, but at the cost of a human life. Do you think that as healthcare providers, we react differently when a patient is sick, from side effects to our recommendations, as opposed to sick from their disease? Dr. Ricky Leiter: I think we probably do. It's hard because I think every patient in every case pulls at us in different directions. And this case was Carlos, who I called him, it was such a challenging situation for so many reasons. He was young. He really couldn't communicate with us. We were talking to his mom. Like, there were so many layers to this. But I think you're right. that underlying this, there's a sense of “We did everything we could beautifully, to cure him of his disease, and now he's dying of that, and what does that mean for us as clinicians, physicians. That becomes really hard and hard to sit with and hold as we're going back every day. And I say that as the palliative care consultant. So I can only imagine for the oncology team caring for him, who had taken him through this, what that felt like. Dr. Mikkael Sekeres: Well, you describe, again, beautifully in the piece, how the nursing staff would approach you and were so relieved that you were there. And it was, you know, you got the sense- I mean, obviously, it's tragic because it's a young person who died, but you almost got the sense there was this guilt among the providers, right? Not only is it a young person dying, but dying from graft versus host disease, not from leukemia. Dr. Ricky Leiter: Absolutely. There was guilt because of what he was dying of, because of how he was dying that he was so uncomfortable and it took us so long to get his pain under control and we really couldn't get him that balance of pain control and alertness that we always strive for was pretty much impossible from the beginning. And so it was layer upon layer of distress and guilt and sadness and grief that we could just feel every day as we stepped onto the floor. Dr. Mikkael Sekeres: Yeah. I don't know if you've ever read- there's a biography of Henry Kaplan, who was considered the father of radiation therapy, where there was this incredible moment during his career when he presented at the AACR Annual Meeting the first cures for cancers, right? No one believed it. It was amazing, actually curing cancer. And then a couple years later, people started dribbling into his clinic with cancers because of the radiation therapy he gave, and he actually went into a clinical depression as a result of it. So it can affect providers at such a deep level. And I think there's this undiscussed guilt that permeates the staff when that happens. Dr. Ricky Leiter: Absolutely, absolutely. It's right there under the surface. And we rarely give ourselves the space to talk about it, right? To really sit down and say, how are we approaching this situation? How do we feel about it? And to sit with each other and acknowledge that this is horrible. It's a horrible situation. And we feel guilty and we feel sad and we feel grief about this. Dr. Mikkael Sekeres: It's been just terrific getting to know you and to read your piece, Ricky Leiternd, a we really appreciate your writing. Keep doing what you do. Dr. Ricky Leiter: Oh, thank you so much. It's a privilege to get the piece out there and particularly in JCO and to be here with you. So I really appreciate it. Dr. Mikkael Sekeres: Until next time, thank you for listening to JCO's Cancer Stories: The Art of Oncology. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all of ASCO's shows at asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Like, share and subscribe so you never miss an episode and leave a rating or review.  Guest Bio: Dr. Ricky Leiter is from the Dana-Farber Cancer Institute.

Sifting through the overwhelming amount of books, news articles, social media influencers, pop-up speaker events, and retreats for menopause is overwhelming, confusing, and expensive. How should midlife women navigate menopause feeling lost, alone, and confused by conflicting information that is supposed to make us healthier, stronger, and more resilient?There's a lot of trial and error and good money spent on products, providers, treatments, and at-home devices that don't live up to their promises. Today, you will walk away with golden nuggets of evidence-based and practical strategies to help you navigate midlife and beyond. This episode covers how to know if the information that you are hearing or reading is evidence-based, why research on women in menopause is complicated to decipher, the nuances of weight resistance training versus cardio exercise, what's most important for midlife women nutritionally, and how to properly eat around your workouts. We also cover how to read protein powder labels and what to look for in amino acids, why creatine is a game-changer for women beyond muscle health, and how to strategize getting restorative sleep. Dr. Rachele Pojednic is an international authority on nutrition, supplementation, and physical activity interventions for muscle physiology, performance, and recovery. She received her PhD from Tufts University Friedman School of Nutrition Science and Policy and completed her postdoctoral training at Harvard Medical School at the Joslin Diabetes Center and Spaulding Rehabilitation Hospital. She has a faculty appointment at Stanford University and holds research appointments at the Institute of Lifestyle Medicine at Harvard Medical School and Edith Cowan University's Nutrition and Health Innovation Research Institute. She has received NIH research funding from the National Heart Lung and Blood Institute (NHLBI) and the Vermont Biomedical Research Network (VBRN), an NIH IDeA Network of Biomedical Research Excellence (INBRE) program. She currently serves on the Board of Governors for the American College of Sports Medicine (ACSM) Exercise Is Medicine® initiative. Dr. Pojednic has been an active fitness professional for over 20 years as a nutrition educator and coach for Olympic, Division I sports, and tactical athletes. She has a passion for science communication and is regularly featured in outlets such as NPR, Sirius Doctor Radio, Time, the Wall Street Journal, STAT News, Popular Science, Self, Shape, Women's Health, Forbes, and Runners World.Medical Disclaimer:By listening to this podcast, you agree not to use this podcast as medical advice or to make any lifestyle changes to treat any medical condition in yourself or others. Consult your physician for any medical issues that you may be having. This entire disclaimer also applies to any of the guests on my podcast.Connect with Rachele:Website: https://www.rachelepojednic.com/IG: @rachelepojednic2004 YouTube: @RachelePojednic_PhDCourses: https://strongprocess.com/Stay connected with JFW:Watch on my YouTube channel: https://www.youtube.com/@jillfooswellness/videosFollow me on Instagram: https://www.instagram.com/jillfooswellness/Follow me on Facebook: https://www.facebook.com/jillfooswellnessGrab discounts on my favorite biohacking products: https://www.jillfooswellness.com/health-productsEnjoy 20% savings and free shipping at Fullscript for your favorite supplements by leading brands:https://us.fullscript.com/welcome/jillfooswellnessSubscribe to the JFW newsletter at www.jillfooswellness.com and receive your FREE Guide on How To Increase Your Protein in 5 Easy Steps and your free Protein Powder Recipe Ebook. Schedule your complimentary 30-minute Zoom consultation here:https://calendly.com/jillfooswellness/30-minute-zoom-consultations

Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack back to the program to discuss the latest hospital price transparency requirements that began in 2025, how many hospitals are actually following these regulations, and what effect noncompliance has on consumers' access to health care.Check out a recently released Health Policy brief from Derek Griffith and Andrew Twinamatsiko exploring the laws and policies prohibiting the discussion of what the Trump administration labeled “divisive concepts” and their impact on health equity. And we recently unveiled a refresh to our Health Affairs Insider program. Learn more about the recent changes and how to become an Insider today!Watch our Virtual Briefing on Uses of Health Care Price Transparency Data: Status, Innovations, & OpportunitiesRelated Articles:Many hospitals still aren't complying with price transparency rule: OIG (Healthcare Dive)HHS: Nearly half of hospitals aren't following CMS price transparency rule (Healthcare Brew)Latest updates to hospital price transparency rules aim to make the data more useful (Stat News)

The murder of a healthcare CEO has led to an overdue conversation about health insurance in the US. The reaction to the news is revealing a visceral anger about the unfairness and dysfunction of how we pay for healthcare. What makes our system so frustrating for people? And what are the solutions? On Say More this week, host Shirley Leung turns to Casey Ross, an investigative reporter with Stat News and Dr. Vikas Saini, a cardiologist who runs the Lown Institute here in Massachusetts. Email us at saymore@globe.com. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the fatal shooting of UnitedHealthcare's chief executive caused public outcry against the health care industry, Rachel Cohrs Zhang, chief Washington correspondent for STAT News, examines what Congress is trying to do to fix a system that many Americans think is broken.

 The fatal shooting of UnitedHealthcare's chief executive has led to public outcry against the health insurance industry.On Today's Show:Rachel Cohrs Zhang, chief Washington correspondent for STAT News, examines what Congress is trying to do to fix a system that many Americans think is broken. 

The US saw a significant drop in the number of drug overdose deaths. The Trump administration has a shot at keeping the trend going. STAT News's addiction reporter, Lev Facher, explains. This episode was produced by Haleema Shah, edited by Amina Al-Sadi, fact-checked by Laura Bullard, engineered by Patrick Boyd, and hosted by Noel King. An addiction recovery billboard in Minneapolis. Photo by Michael Siluk/UCG/Universal Images Group via Getty Images. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Gothamist's Brittany Kriegstein explains who police just arrested. STAT News's Bob Herman explains the anger resonating against UnitedHealthcare. This episode was produced by Miles Bryan and Hady Mawajdeh, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Patrick Boyd and Rob Byers, and hosted by Sean Rameswaram. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Luigi Mangione, the suspect in the shooting of UnitedHealthcare CEO Brian Thompson, in an Altoona Police Department handout photo. Photo by Altoona Police Department via Getty Images. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Businessman and entertainer Mark Cuban has long had an interest in health care, and a mission to disrupt the pharmaceutical industry.Torie Bosch, host of First Opinion, a podcast from STAT News, speaks with Cuban about one of his latest ventures Cost Plus Drugs - Mark's efforts to drive down prescription drug prices. Guests:Torie Bosch, Editor, First Opinion, STAT NewsMatt Herper, Senior Writer, Medicine, STAT NewsMarc Cuban, Co-Founder Cost Plus Drugs EntrepreneurLearn more and read a full transcript on here.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/european-studies

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/french-studies

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode features a conversation with Dr. Cindy Ermus on her recently published book, The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World. Published by Cambridge University Press, The Great Plague Scare of 1720 follows the Plague of Provence from 1720 to 1722 to understand new forms of contagion and its management. As one of the last major epidemics of the plague to strike Western Europe, the Plague of Provence generated a public health crisis that impacted the social, commercial, and diplomatic choices of France, which eventually spread the public health crisis to Italy, Great Britain, Spain, and their overseas colonies. In this transnational, transoceanic study, The Great Plague Scare of 1720 reveals how crisis in one part of the globe transcends geographic boundaries and influences society, politics, and public health policy in regions far from the epicenter of disaster. Cindy Ermus is the Charles and Linda Wilson Associate Professor in the History of Medicine, and Director of the Humanities in Medicine Program at the University of Nebraska-Lincoln. She specializes in the history of medicine and the environment, especially catastrophe and public health crisis management, in eighteenth-century France and the Atlantic World. In addition to The Great Plague Scare of 1720: Disaster and Diplomacy in the Eighteenth-Century Atlantic World (Cambridge University Press, 2023), she is also the author of Urban Disasters (Cambridge UP, 2023). Currently, she is at work on a co-authored global history of epidemics (with Claire Edington). Her work has been featured in The Washington Post, The Atlantic, The Verge, Stat News, and The Miami Herald, and she has been a guest on BBC World News, Univision, Al-Jazeera, and others. She is also co-series editor for France Overseas of the University of Nebraska Press, and co-founder and co-executive editor for the digital, open-access publication AgeofRevolutions.com. Donna Doan Anderson (she/her) is a research assistant professor in History at the University of Nebraska-Lincoln. Isidro Gonzalez (he/him) is a pre-doctoral fellow of History at Claremont McKenna College. Learn more about your ad choices. Visit megaphone.fm/adchoices

President-elect Trump has named two more people to his administration: investment banker Howard Lutnick as commerce secretary and Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services. The noted TV personality and heart surgeon will oversee programs that provide health care coverage to about half of all Americans. Amna Nawaz discussed more with Lev Fasher of STAT News. PBS News is supported by - https://www.pbs.org/newshour/about/funders

On this episode of Momentum: A Race Forward Podcast, Race Forward President Glenn Harris speaks with Dr. Aletha Maybank, Chief Health Equity Officer and Senior Vice President at the American Medical Association (AMA), to explore the transformative work underway to advance health equity in the United States. The discussion underscores the AMA's pivotal role as the trailblazer sponsor of the Facing Race 2024 conference in St. Louis, Missouri. The upcoming conference will spotlight the AMA's efforts by hosting a session in the National Health Equity Grand Rounds, designed to foster a deeper national dialogue on health disparities and equity-driven healthcare solutions.Dr. Maybank recounts her journey since assuming her role in 2019, focusing on the comprehensive strategies she has implemented to embed health equity into every facet of the American Medical Association's policies and daily operations. Her leadership reflects a mission to reshape organizational culture, shifting the American Medical Association's focus toward health equity as a core priority and collective responsibility. This effort, intensified by the dual crises of the COVID-19 pandemic and the public outrage following George Floyd's murder, addresses the need for structural and systemic reforms in healthcare to combat longstanding inequities.A key initiative discussed is the Rise to Health Coalition—a wide-reaching collaborative effort uniting healthcare systems, professional societies, and advocacy groups with the goal of dismantling entrenched inequities within the medical field. Dr. Maybank provides detailed insights into the coalition's initial accomplishments, such as identifying and eliminating discriminatory algorithms in healthcare that have historically resulted in biased patient care and outcomes. She outlines ongoing reforms that aim to address inequitable healthcare structures and reshape how care is delivered across the nation.The conversation also critiques dominant societal narratives that frame health as primarily a matter of individual responsibility. Dr. Maybank challenges these narratives, emphasizing the need to recognize and address social determinants of health, such as poverty, housing, and systemic discrimination, which disproportionately impact marginalized populations. This paradigm shift is crucial to developing equitable healthcare systems that prioritize collective well-being and access.Dr. Maybank also shares the challenges and resistance she faces in her leadership role, including navigating personal threats and opposition to her equity-driven agenda. She reflects on the need for resilience, solidarity, and finding moments of joy in the struggle for systemic change. Her reflections on leadership, partnership, and the American Medical Association's  ongoing National Health Equity Grand Rounds reveal how cross-sector collaboration and community-building are essential in driving sustainable change in healthcare.Resources: Dr. Aletha Maybank (American Medical Association) https://bit.ly/4etnuGZNational Health Equity Grand Rounds (Registration Link) https://www.healthequitygrandrounds.org/“Q&A: AMA's chief health equity officer on ridding medicine of racial essentialism” (via Stat News)https://bit.ly/3YHzKxO“From process to outcome: working toward health equity” (via Nature Journal) https://bit.ly/3US8vPP

President-elect Trump has named two more people to his administration: investment banker Howard Lutnick as commerce secretary and Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services. The noted TV personality and heart surgeon will oversee programs that provide health care coverage to about half of all Americans. Amna Nawaz discussed more with Lev Fasher of STAT News. PBS News is supported by - https://www.pbs.org/newshour/about/funders

It's often not the big power moves that change our lives; it's the small, intentional actions. By focusing on micro-skills, even the most ambitious goals become achievable.In this episode, we talk with Drs. Adaira Landry and Resa E. Lewiss about their new book, MicroSkills: Small Actions, Big Impact. We explore how financial literacy, self-presentation, concise communication, and allyship can be developed as essential micro-skills for a successful career. We also navigate workplace dynamics, including recognizing and addressing issues like mansplaining and bropropriating. Finally, we discuss the nuances of learning when to say “yes” or “no,” and the art of timely, respectful communication.

Race has long been a factor in how doctors approach diagnoses— removing it has proved a challenge. Katie Palmer, Health Tech Correspondent for Stat News, joins host Krys Boyd to discuss the bias baked into medicine for decades, how it contributes to system disparities, and why the work to change it is so difficult. Her series “Embedded Bias” is written with co-author Usha Lee McFarling.

My guests for this episode include science ‘influencer' Mr. @Evopsychgoogle, evolutionary biologist Kevin Bird @thebirdmaniac on Twitter and anthropologist Cathryn Townsend @cathryntownsend On this part of the panel we discuss the panelists' recent article in Stat News (linked below), on how this type of junk science continues to be legitimized to this day, despite glaring errors in the data. We discuss self-described ‘scientific racist' Richard Lynn as well as E.O. Wilson, Steven Pinker, Sam Harris, Charles Murray and their contributions to race ‘science'. We also talk more broadly about how the Intellectual Dark Web has played a major role in reviving it in recent years. Links: The Panelists' article that we discussed in the beginning of the episode: Journals that published Richard Lynn's racist ‘research' articles should retract them https://www.statnews.com/2024/06/20/richard-lynn-racist-research-articles-journals-retractions/ My previous episodes with Mr. @evopsychgoogle: Pt 1 - https://open.spotify.com/episode/4jSFhcmT6xNJ4JOwbEkscE?si=JnGZZ36GTNSVYKr0dYz4Fg Pt 2 - https://open.spotify.com/episode/5gvuP3xLyqKSpJgTjf43A3?si=AenT06jVTuGNc-pd6W4BtA My Miniseries on Sam Harris ‘Woking Up' https://open.spotify.com/playlist/1caIpbHnvDjKu0Ph4DA0Nb?si=DxI59yjtRjuDV7rQSv9cEw&pi=u-kmAFEyuTRNiJ If you'd like to support the show pls subscribe to the YouTube channel here: https://www.youtube.com/@politeconversationspodcast —— Other Related articles: Quinn Slobodian article about the Pioneer Fund and The Bell Curve: https://thebaffler.com/salvos/the-white-man-unburdened-slobodian-schrader The Tainted Sources of The Bell Curve: https://www.nybooks.com/articles/1994/12/01/the-tainted-sources-of-the-bell-curve/ Free book by William Tucker on The Bell Curve: https://link.springer.com/book/10.1007/978-3-031-41614-9 Primary research articles debunking Lynn: https://www.sciencedirect.com/science/article/pii/S104160801000035X?via%3Dihub https://www.sciencedirect.com/science/article/pii/S1041608009001071?via%3Dihub https://www.sciencedirect.com/science/article/pii/S0191886909003675?via%3Dihub https://www.sciencedirect.com/science/article/pii/S0160289609001470?via%3Dihub https://www.sciencedirect.com/science/article/pii/S0160289609000634?via%3Dihub https://www.sciencedirect.com/science/article/pii/S0191886909002475?via%3Dihub https://osf.io/preprints/psyarxiv/tzr8c https://osf.io/preprints/psyarxiv/26vfb https://www.sciencedirect.com/science/article/pii/S1041608024000141?via%3Dihub

In this enlightening episode of The Reflective Mind Podcast, Dr. Reid speaks with Dr. Mara Gordon, a pioneer in the field of size-inclusive medicine. Dr. Gordon shares insights into her comprehensive approach to healthcare that prioritizes patients of all body sizes.We delve into how size-inclusive medicine goes beyond the numbers on a scale, focusing on holistic patient care, individualized treatment plans, and the importance of addressing weight bias in the medical field. Dr. Gordon discusses the impact of size discrimination, and practical strategies for other healthcare professionals to foster a more inclusive environment.Join us for an eye-opening conversation that redefines what it means to provide compassionate and equitable care. Whether you're a healthcare professional, a patient, or simply curious about how to make the medical system more inclusive, this episode offers valuable perspectives and actionable insights.Thanks for reading A Mind of Her Own! Subscribe for free to receive new posts and support my work.Medical Students for Size-Inclusive Medicine can be found at https://sizeinclusivemedicine.org/our-story/Authors Recommended in Episode:* Lindy West* Roxane Gay* Kiese LaymonDr. Reid on Instagram: @jenreidmdThanks for listening to The Reflective Mind Podcast! Listening is free for all, so please share it with everyone!Also check out Dr. Reid's regular contributions to Psychology Today: Think Like a ShrinkDr. Mara Gordon is a family physician and writer based in Philadelphia. Her writing has appeared on NPR, in the New York Times, the Atlantic, the Philadelphia Inquirer, STAT News, and elsewhere. Please check out her newsletter, Chief Complaint, for more reflections on medicine, parenting, gender, and fatphobia.Dr. Gordon worked in public health in Tanzania and Malawi before returning home to attend medical school at the Perelman School of Medicine at the University of Pennsylvania. She stayed at Penn for residency training in Family Medicine and Community Health and was the 2018-2019 Health & Media Fellow at National Public Radio.She is now on the faculty at Cooper Medical School of Rowan University in Camden, NJ, where she serves as a primary care physician for patients of all ages and teach medical students. Seeking a mental health provider? Try Psychology TodayNational Suicide Prevention Lifeline: 1-800-273-8255Dial 988 for mental health crisis supportSAMHSA's National Helpline - 1-800-662-HELP (4357)-a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.Disclaimer:The views expressed on this podcast reflect those of the host and guests, and are not associated with any organization or academic site. The information and other content provided on this podcast or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only.If you or any other person has a medical concern, you should consult with your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that have read on this website, blog or in any linked materials. If you think you may have a medical emergency, call your doctor or emergency services (911) immediately. You can also access the National Suicide Help Line at 1-800-273-8255 or call 988 for mental health emergencies. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit amindofherown.substack.com

Murky rules for health care coverage are not new, but now, companies are increasingly turning to AI to help make complex decisions about medical decisions — leading to some devastating mistakes. STAT News reporters Casey Ross and Bob Herman were recently named finalists for the Pulitzer Prize for exposing how the large insurer UnitedHealth Group used AI to deny care. On Say More, they talk to Globe Ideas editor Brian Bergstein about the dangers of AI in health care. Email us at saymore@globe.com. Click here to see Casey and Bob's reporting. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

En este episodio de El Siglo 21 es Hoy, te llevamos a un análisis profundo de la película Gattaca: Experimento Genético y su impacto en el contexto actual de la genética y la bioética. Capítulos:00:00 Episodio 154504:20 La Revolución Genética en la Sombra05:36 Gattaca08:15 Doctor Cantillo10:38 Prevención Genética: Tratando Enfermedades Antes de que Aparezcan12:47 El Destino en el ADN: Predicciones de Vida y Muerte Desde el Nacimiento16:01 Andrew Niccol: La Mente Detrás de Gattaca y su Compleja Visión del Futuro19:15 Diseñando el Futuro: La Selección de Rasgos en los Hijos22:54 Cuando la Perfección Falla: Cómo un Accidente Abre Nuevas Oportunidades28:31 La Ciencia Oculta en las Letras33:31 Elegir Pareja en Gattaca: La Ciencia Reemplaza al Corazón37:04 Meritocracia y Determinismo Genético en Gattaca44:37 Simbolismo Visual en Gattaca: La Escalera en Espiral y la Doble Hélice del ADN48:58 Bioética y Discriminación Genética en Gattaca52:21 El ADN Bajo Lupa: La Privacidad Genética en Riesgo56:00 CréditosGattaca, una obra maestra de la ciencia ficción, nos transporta a un futuro donde la manipulación genética no solo es posible, sino que define la vida de los individuos desde el momento en que nacen. Exploramos cómo en este mundo distópico, la selección de rasgos genéticos predice capacidades, enfermedades, y hasta la expectativa de vida, desafiando los límites de la ética en la ciencia.Conectamos estos conceptos con los avances reales en la tecnología de los cromosomas artificiales, un tema que ha generado gran expectación en la comunidad científica. Abordamos preguntas cruciales como: ¿Hasta dónde debería llegar la intervención genética en los seres humanos? ¿Es posible tratar enfermedades antes de que aparezcan? ¿Qué implicaciones tiene la pérdida de la privacidad genética en un mundo donde el ADN se convierte en el nuevo "currículum"?¿Por qué temas como la inteligencia artificial dominan las conversaciones actuales, mientras que la revolución genética, que tiene el potencial de transformar radicalmente nuestras vidas, permanece en la sombra? También analizamos el simbolismo y los elementos visuales de Gattaca, como la escalera en espiral que recuerda a una doble hélice de ADN, y cómo estos detalles enriquecen la narrativa.Este episodio es una invitación a reflexionar sobre los dilemas bioéticos que Gattaca plantea, y que cada vez se acercan más a nuestra realidad. ¿Es la ciencia ficción realmente ficción, o estamos viendo los primeros pasos hacia un futuro donde la genética lo dicta todo? Acompáñanos en esta exploración de cómo la película Gattaca no solo anticipa futuros escenarios genéticos, sino que también nos advierte sobre los peligros de una sociedad obsesionada con la perfección genética y el control total del ADN.Bibliografía"Gattaca (1997) - Película completa," OK.RU."Gattaca: The Impact of Science Fiction on Genetic Research," David A. Kirby: The New Eugenics in Cinema."The New Eugenics in Cinema: Genetic Determinism and Gene Therapy in GATTACA," Science Magazine."French Anderson, El Pionero de la Terapia Génica," Voz de América.Groer, Annie, y Debra Gerhart. "Father of Gene Therapy, W. French Anderson, on Science and Scandal," STAT News.Conviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/el-siglo-21-es-hoy--880846/support.

En este episodio de El Siglo 21 es Hoy, te llevamos a un análisis profundo de la película Gattaca: Experimento Genético y su impacto en el contexto actual de la genética y la bioética. Capítulos:00:00 Episodio 154504:20 La Revolución Genética en la Sombra05:36 Gattaca08:15 Doctor Cantillo10:38 Prevención Genética: Tratando Enfermedades Antes de que Aparezcan12:47 El Destino en el ADN: Predicciones de Vida y Muerte Desde el Nacimiento16:01 Andrew Niccol: La Mente Detrás de Gattaca y su Compleja Visión del Futuro19:15 Diseñando el Futuro: La Selección de Rasgos en los Hijos22:54 Cuando la Perfección Falla: Cómo un Accidente Abre Nuevas Oportunidades28:31 La Ciencia Oculta en las Letras33:31 Elegir Pareja en Gattaca: La Ciencia Reemplaza al Corazón37:04 Meritocracia y Determinismo Genético en Gattaca44:37 Simbolismo Visual en Gattaca: La Escalera en Espiral y la Doble Hélice del ADN48:58 Bioética y Discriminación Genética en Gattaca52:21 El ADN Bajo Lupa: La Privacidad Genética en Riesgo56:00 CréditosGattaca, una obra maestra de la ciencia ficción, nos transporta a un futuro donde la manipulación genética no solo es posible, sino que define la vida de los individuos desde el momento en que nacen. Exploramos cómo en este mundo distópico, la selección de rasgos genéticos predice capacidades, enfermedades, y hasta la expectativa de vida, desafiando los límites de la ética en la ciencia.Conectamos estos conceptos con los avances reales en la tecnología de los cromosomas artificiales, un tema que ha generado gran expectación en la comunidad científica. Abordamos preguntas cruciales como: ¿Hasta dónde debería llegar la intervención genética en los seres humanos? ¿Es posible tratar enfermedades antes de que aparezcan? ¿Qué implicaciones tiene la pérdida de la privacidad genética en un mundo donde el ADN se convierte en el nuevo "currículum"?¿Por qué temas como la inteligencia artificial dominan las conversaciones actuales, mientras que la revolución genética, que tiene el potencial de transformar radicalmente nuestras vidas, permanece en la sombra? También analizamos el simbolismo y los elementos visuales de Gattaca, como la escalera en espiral que recuerda a una doble hélice de ADN, y cómo estos detalles enriquecen la narrativa.Este episodio es una invitación a reflexionar sobre los dilemas bioéticos que Gattaca plantea, y que cada vez se acercan más a nuestra realidad. ¿Es la ciencia ficción realmente ficción, o estamos viendo los primeros pasos hacia un futuro donde la genética lo dicta todo? Acompáñanos en esta exploración de cómo la película Gattaca no solo anticipa futuros escenarios genéticos, sino que también nos advierte sobre los peligros de una sociedad obsesionada con la perfección genética y el control total del ADN.Bibliografía"Gattaca (1997) - Película completa," OK.RU."Gattaca: The Impact of Science Fiction on Genetic Research," David A. Kirby: The New Eugenics in Cinema."The New Eugenics in Cinema: Genetic Determinism and Gene Therapy in GATTACA," Science Magazine."French Anderson, El Pionero de la Terapia Génica," Voz de América.Groer, Annie, y Debra Gerhart. "Father of Gene Therapy, W. French Anderson, on Science and Scandal," STAT News.Conviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/el-siglo-21-es-hoy--880846/support.

In this episode, we listen back to a stellar panel discussion we hosted for clients and prospects at Microsoft's Burlington headquarters in Massachusetts. We brought industry leaders on stage with a wealth of knowledge and experience from various corners of the tech universe. Our moderator for the conversation was Chris Seferlis, Account Technology Strategist at Microsoft and renowned author of "Practical Guide to Azure Cognitive Services." Chris was joined by:Dante Ballerini, the VP of Information Technology at Cambridge Isotope Laboratories, Mike Norman, Head of Product and Innovation at STAT News, and Tony Berry, Senior Solutions Architect at BrainSell and Co-founder of Interloop.The panel discussion explores their data-centric strategies, key challenges faced and how they are being overcome, the positive impact of focusing on their data foundations, and what's planned for the future.

The hack on Change Healthcare left hundreds, if not thousands, of providers without the ability to obtain insurance approval or payment for everything from prescriptions to surgeries and it shed new light on a part of the health care system that is often overlooked. Dan Weissmann, the host of An Arm and a Leg podcast, speaks with reporters Brittany Trang of Stat News and Maureen Tkacik of The American Prospect about the hack and what it is telling us about antitrust concerns in the health care industry.

Send us a Text Message.Today's interview w/ authors and emergency room physicians Dr. Adaira Landry and Dr. Resa Lewiss focuses on the concept of Microskills, which are built on a singular principle: Every big goal, complicated task, healthy habit, and even what we think of as character traits can be broken down into small, learnable skills that can be practiced and incorporated in real-time. They'll share why success does not have to mean sacrificing our own wellbeing – but rather that can be the key to success in the first place. Dr. LANDRY is an assistant professor at Harvard Medical School and an emergency medicine physician at Brigham and Women's Hospital and co-founded Write In Color, a non-profit teaching others the art and skill of writing. She lives in Boston with her three daughters and husband.Dr. LEWISS' resume is similarly jam-packed. Among a long list of accomplishments, she is a professor of emergency medicine at The University of Alabama at Birmingham and hosts the Visible Voices Podcast. She lives in Philadelphia.Combined, Drs. Landry and Lewiss have written for CNBC, Fast Company, Harvard Business Review, Nature, Science, Slate, STAT News, Teen Vogue, Vogue, USA Today, and the Philadelphia Inquirer, and been quoted and featured in The New York Times, The New Yorker, The Guardian, and the Huffington Post.Looking for weekly tips, tricks and turbo boosts to enhance your life? Sign up for the CATALYST COMPASS here, a brief weekly compilation of ideas, evidence-based concepts and encouragement to improve your personal and professional life! Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/ YouTube Coaching Channel https://www.youtube.com/c/CoachingChannel Contact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.

Episode 9 features a conversation on opioids with Andrew Kolodny MD. Dr. Kolodny is a leading expert on the opioid crisis and serves as President of Health Professionals for Responsible Opioid Prescribing (PROP). We chat about the opioid epidemic in the US over the years, the covert marketing strategies used to sell opioids, and opioid prescribing guidelines. Pharmanipulation is produced by PharmedOut, a project at Georgetown University Medical Center that advances evidence-based prescribing. Additional Resources PROP's Website: https://www.supportprop.org/ PharmedOut on Opioids: https://sites.google.com/georgetown.edu/pharmedout/advocacy/pharmedout-on-opioids PharmedOut's Journal Article, “Survey of opioid prescribing among dentists indicates need for more effective education regarding pain management” in Journal of the American Dental Association: https://pubmed.ncbi.nlm.nih.gov/34689958/ “Years into an addiction crisis, a med school lecture still minimized opioid risks” by Ed Silverman for STAT News, link: https://www.statnews.com/pharmalot/2024/02/07/opioid-addiction-pain-nova-southeastern-university-florida/ Fact sheet on opioid marketing: https://georgetown.app.box.com/s/3fqr4f0nl4jnviwrcxhn6muaxqqptgsx Summaries of key articles on opioid marketing: https://georgetown.app.box.com/s/xt2rhk3tinq0rqgn9bz2dozm2w4dv84c

Today, we're going to talk about how psychedelics alter our perception of reality and what that says about... reality! Welcome  to part two of our conversation with Stanford anesthesiologist and psychedelics researcher Boris Heifets! Last time, we talked with Boris about the question of why psychedelics help people with mental health disorders. This week, we're going to dive into a different question, which is to explore how psychedelics work in the brain. How are they able to alter something as fundamental as our perceptions of reality — and could understanding these effects teach us about the nature of our everyday perceptions?Learn more:Review: Therapeutic mechanisms of psychedelics and entactogens (Heifets and Olsen, 2024)As psychedelics near approval, there's no consensus on how they work (STAT News, 2023)How do psychedelics work? (Carhart-Harris, 2019)Heifets Lab websiteEpisode creditsThis episode was produced by Michael Osborne at 14th Street Studios, with production assistance by Morgan Honaker. Our logo is by Aimee Garza. The show is hosted by Nicholas Weiler at Stanford's Wu Tsai Neurosciences Institute. Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience. Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

Artificial intelligence has become a big part of medicine — reading images, formulating treatment plans and developing drugs. But a recent investigation by Stat News found that some insurers overrely on an algorithm to make coverage decisions for seniors on Medicare Advantage, a Medicare plan offered by private insurers. Marketplace’s Meghan McCarty Carino spoke with Casey Ross, who co-reported the story. He said an algorithm predicted how long patients needed care and coverage was curtailed to fit that calculation.

Artificial intelligence has become a big part of medicine — reading images, formulating treatment plans and developing drugs. But a recent investigation by Stat News found that some insurers overrely on an algorithm to make coverage decisions for seniors on Medicare Advantage, a Medicare plan offered by private insurers. Marketplace’s Meghan McCarty Carino spoke with Casey Ross, who co-reported the story. He said an algorithm predicted how long patients needed care and coverage was curtailed to fit that calculation.

In this weekend's episode, three segments from this past week's Washington Journal First – Associated Press economy reporter Chris Rugaber discusses the Federal Reserve's projections on interest rates and outlook for the U-S economy. Then – Lev Facher – correspondent for the health news website STAT News' -- discusses his year-long investigation into opioid addiction in the US. Plus – a closer look at the political turmoil rocking Haiti with Queens College political science professor François Pierre-Louis. Learn more about your ad choices. Visit megaphone.fm/adchoices

Reporter Bob Herman from STAT News unpacks his blockbuster investigation about the country's biggest health care company. Covering the American health care system means we tell some scary stories. But this episode is almost like a horror movie. It's got some of Hollywood's favorite tropes: Machines taking over. Monsters from separate franchises meeting face to face in a new movie, like Godzilla and King Kong, or Jason and Freddy. And a couple perceptive folks warning everyone, ”Hey, look, something really bad is happening!” Those folks are Bob and his STAT News colleague Casey Ross. The monsters are United HealthGroup — a “behemoth” as one expert called them in an episode from last year — and Medicare Advantage, which we looked at in our last episode. And the “machines” belong to United.Bob describes what some of United's own employees said about the result: “For some of us, it's creating this moral crisis. Like we know that we are having to listen to an algorithm to essentially kick someone out of a nursing home, even though we know that they can barely walk 20 feet.” Scary stuff. But Bob and Casey's reporting has caught the eye of some powerful people in government, and right now, Medicare Advantage plans are on notice from the federal Centers for Medicare and Medicaid Services, the U.S. Senate is holding hearings, and the Department of Justice reportedly has an anti-trust investigation in the works. Here's a transcript of this episode. Send your stories and questions. Or call 724 ARM-N-LEG.And of course we'd love for you to support this show. Hosted on Acast. See acast.com/privacy for more information.

For our final episode of 2023, we're throwing a holiday party with music, festive fascinator hats and drinks. We’ll also get to some big medical news: For the first time, the FDA approved gene therapies to treat sickle cell disease, which affects mostly Black people in the United States. And, the head of OPEC is meddling in climate talks at COP28. Plus, we'll play a holiday-themed round of our favorite game, Half Full/Half Empty! Here’s everything we talked about today: “OPEC Leader Tells Members to Block Any Climate Summit Deal to Curb Fossil Fuels” from The New York Times “FDA Approves Breakthrough Sickle Cell Disease Gene Therapies” from HuffPost “US FDA approves two gene therapies for sickle cell disease” from Reuters “After living with sickle cell disease for 39 years, I’m both excited and skeptical about the newly approved gene therapies” from Stat News “Buy now, pay later hit an all-time high on Cyber Monday” from Marketplace “A Brief History of the White Elephant Party” from The New York Times “Taylor Swift and Travis Kelce Wore Squirrel Sweaters, Maybe” from Marie Claire “Amazon Is Packed with Festive Outdoor Christmas Decorations” from People “How to get through a holiday party at work without embarrassing yourself” from NPR We’ll be back with new episodes on Jan. 8. Until then, if you've got a question, comment or submission for a state drink, send them our way. We're at 508-UB-SMART or email makemesmart@marketplace.org.

In 2019, the Mexican government instituted a new rule that took mascots like El Tigre Toño off of high-sugar foods. The food industry fought back. And now a similar fight may be coming to the United States. Abdul reflects on the role of marketing in our food environment. Then he speaks with Nick Florko, a reporter at STAT News, about Mexico's struggle to cage the tiger. GoFundMe to support the family of Ady Barkan